Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT

Saved in:
Bibliographic Details
Published in:Journal of Blood Medicine
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552932385882112
collection WordPress RSS
FRELIP Feed Integration
container_title Journal of Blood Medicine
description
discipline_display Hematology
discipline_facet Hematology
format Online Article
RSS Article
genre Journal Article
id rss_article:69113
institution FRELIP
journal_source_facet Journal of Blood Medicine
last_indexed 2026-06-20T21:28:52.253Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT
Hematology
General
Hematology
sub_discipline_display General
sub_discipline_facet General
subject_display Hematology
General
Hematology
subject_facet Hematology
General
Hematology
title ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT
title_alt ATG más ciclofosfamida postrasplante mejora el aclaramiento de ADN-VEB y la EICH en pacientes con enfermedad crónica activa por virus de Epstein-Barr en adultos sometidos a TCH alogénico
L'ATG plus la cyclophosphamide post-transplantation améliore la clairance de l'ADN du VEB et la GVHD chez les patients atteints de maladie active chronique à virus d'Epstein-Barr de l'adulte subissant une HSCT allogénique
ATG mais ciclofosfamida pós-transplante melhora a depuração de EBV-DNA e DECH em pacientes adultos com doença de Epstein-Barr ativa crônica submetidos a TCTH alogênico
title_auth ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT
title_es_txt ATG más ciclofosfamida postrasplante mejora el aclaramiento de ADN-VEB y la EICH en pacientes con enfermedad crónica activa por virus de Epstein-Barr en adultos sometidos a TCH alogénico
title_fr_txt L'ATG plus la cyclophosphamide post-transplantation améliore la clairance de l'ADN du VEB et la GVHD chez les patients atteints de maladie active chronique à virus d'Epstein-Barr de l'adulte subissant une HSCT allogénique
title_full ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT
title_fullStr ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT
title_full_unstemmed ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT
title_pt_txt ATG mais ciclofosfamida pós-transplante melhora a depuração de EBV-DNA e DECH em pacientes adultos com doença de Epstein-Barr ativa crônica submetidos a TCTH alogênico
title_short ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT
title_sort atg plus post-transplantation cyclophosphamide improves ebv-dna clearance and gvhd in patients of adult chronic active epstein-barr virus disease undergoing allogeneic hsct
topic Hematology
General
Hematology
url https://www.dovepress.com/atg-plus-post-transplantation-cyclophosphamide-improves-ebv-dna-cleara-peer-reviewed-fulltext-article-JBM